Skip to main content

Suzuki, Benjamin | Regeneron Pharmaceuticals

Ben Suzuki
Benjamin Suzuki, AIA
Exec Director, RE & Facilities Management

With more than 30 years of professional experience, Ben Suzuki is Executive Director, Engineering, Design and Construction at Regeneron, a leading biotechnology company based in Tarrytown, New York, that invents, develops, and commercializes life-transforming medicines for people with serious diseases. In his role for the past five years, Ben leadsall aspects of global capital projects for Regeneron, including strategic planning, engineering, design, construction, life cycle assessments, systems diagnostics, asset management, and compliance. 

Ben oversees a team of more than 70 professionals responsible for planning and managing the design and delivery of real estate projects that facilitate Regeneron’s growth worldwide across 16 locations, covering a total of 5.1 million square feet. Since joining Regeneron in 2018 Ben’s team leads the design and construction of over 3 million square feet and counting. Current US projects include locations in New York, New Jersey, Washington, Massachusetts, and California. Current international project locations include Canada, UK, Europe, Japan and India

Within a broad and expansive portfolio, Ben has undertaken notable projects that have been recognized by the media, industry organizations, and local and state government as highly significant and beneficial to the community and region, including the multi-billion-dollar, multi phased Regeneron Tarrytown Campus Expansion Project. 

Before joining Regeneron in 2018, Ben was the Director of Capital Project Management at Columbia University for over 10 years and a Principal at HOK, where he led science and technology projects for a variety of sectors. His large-scale international experience began with HLW International, focusing on high-tech, life science, and government projects in Asia and the Middle East from 1998 to 2005. Earlier in his career, he worked with the Hillier Group's Science and Technology Studio, focusing on academic, healthcare, and corporate life science companies.

Throughout his 30-year career, Ben has completed projects spanning over 12 million square feet and valued at over $10 billion. His international portfolio covers 13 countries across North America, Europe, the Middle East, and Asia. He has worked with major companies such as Glaxo Smith Kline, Pfizer, Johnson & Johnson, Columbia University, Yale University, and Chase Manhattan Bank, among others. His projects extend to institutions like the Malaysia National Science Center and the Kuwait Civil Service Commission. 

Ben is a licensed architect and is active in the industry with memberships including the AIA, NFPA, and NY Building Congress. 

Ben holds a Bachelor of Architecture from Syracuse University and a Master of Science in Construction Administration from Columbia University.